Asia Pacific Nasal Delivery Devices Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Nasal Delivery Devices Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Nasal Delivery Devices Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Nasal Delivery Devices Market Regional Analysis

6.2 Asia Pacific Nasal Delivery Devices Market Revenue 2017-2027 (US$ Million)

6.3 Asia Pacific Nasal Delivery Devices Market Forecast Analysis

7. Asia Pacific Nasal Delivery Devices Market Analysis – by Drug Type

7.1 Anaesthetics

7.1.1 Overview
7.1.2 Anaesthetics: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Antibiotics

7.2.1 Overview
7.2.2 Antibiotics: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Pain Relief Drugs

7.3.1 Overview
7.3.2 Pain Relief Drugs: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.4 Calcium Supplements

7.4.1 Overview
7.4.2 Calcium Supplements: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.5 Vasoconstrictors

7.5.1 Overview
7.5.2 Vasoconstrictors: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.6 Antihistamines

7.6.1 Overview
7.6.2 Antihistamines: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Asia Pacific Nasal Delivery Devices Market Analysis – by Delivery Technologies

8.1 Spray

8.1.1 Overview
8.1.2 Spray: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Nebulizers

8.2.1 Overview
8.2.2 Nebulizers: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Inhalers

8.3.1 Overview
8.3.2 Inhalers: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Asia Pacific Nasal Delivery Devices Market Analysis – by End User

9.1 Home Care Settings

9.1.1 Overview
9.1.2 Home Care Settings: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Hospitals

9.2.1 Overview
9.2.2 Hospitals: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Clinics

9.3.1 Overview
9.3.2 Clinics: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Asia Pacific Nasal Delivery Devices Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific Nasal Delivery Devices Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 China: Asia Pacific Nasal Delivery Devices Market Breakdown, by Drug Type
10.2.1.1.2 China: Asia Pacific Nasal Delivery Devices Market Breakdown, by Delivery Technologies
10.2.1.1.3 China: Asia Pacific Nasal Delivery Devices Market Breakdown, by End User

10.2.1.2 India: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 India: Asia Pacific Nasal Delivery Devices Market Breakdown, by Drug Type
10.2.1.2.2 India: Asia Pacific Nasal Delivery Devices Market Breakdown, by Delivery Technologies
10.2.1.2.3 India: Asia Pacific Nasal Delivery Devices Market Breakdown, by End User

10.2.1.3 Japan: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Japan: Asia Pacific Nasal Delivery Devices Market Breakdown, by Drug Type
10.2.1.3.2 Japan: Asia Pacific Nasal Delivery Devices Market Breakdown, by Delivery Technologies
10.2.1.3.3 Japan: Asia Pacific Nasal Delivery Devices Market Breakdown, by End User

10.2.1.4 Australia: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.4.1 Australia: Asia Pacific Nasal Delivery Devices Market Breakdown, by Drug Type
10.2.1.4.2 Australia: Asia Pacific Nasal Delivery Devices Market Breakdown, by Delivery Technologies
10.2.1.4.3 Australia: Asia Pacific Nasal Delivery Devices Market Breakdown, by End User

10.2.1.5 Rest of Asia-Pacific : Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Nasal Delivery Devices Market Breakdown, by Drug Type
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Nasal Delivery Devices Market Breakdown, by Delivery Technologies
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Nasal Delivery Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 GlaxoSmithKline plc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 AstraZeneca

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Pfizer Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 BD

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Sanofi

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck & Co., Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Cadila Pharmaceuticals Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Novartis AG

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Dr. Reddy's Laboratories

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific Nasal Delivery Devices Market

Analysis by Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, and Others); Delivery Technologies (Spray, Nebulizers, Inhalers, and Others); End User (Home Care Settings, Hospitals, and Clinics); and Country